Graves Disease Study
If you or a loved one is living with Graves’ disease, a clinical study may be able to help. Click the button below to learn more about the study.
Who’s Included?
Adults; All genders
18–65
Drug & Formulation
BHV-1300
Injection
Possibility of Placebo
Graves’ disease is an autoimmune disorder that affects the thyroid gland, a small gland located in your neck. It occurs when the immune system mistakenly attacks the thyroid, causing it to become overreactive and produce too many thyroid hormones – a condition called hyperthyroidism.
Graves’ disease can cause problems throughout the entire body. Common symptoms include anxiety, a fast or irregular heartbeat, tremors, difficulty sleeping, fatigue, excessive sweating, rapid bowel movements, weight loss, and changes in the menstrual cycle. Some people can develop an enlarged thyroid and serious eye problems, often referred to as thyroid eye disease.
Although Graves’ disease primarily affects the thyroid, it can cause complications in other parts of the body if left untreated.
- You must be 18-65 years old.
- Participants must have confirmed Graves’ disease.
- Participant has a history of hyperthyroidism not caused by Graves’ disease.
- History of treatment with radioactive iodine or thyroid surgery.
Learn more about the benefits of joining our trial and see if you qualify today!
Frequently Asked Questions
About 15 people will participate in this study.
The study is being conducted on behalf of Biohaven .
Visit the See If You Qualify page if you are interested in participating in this study.